Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.971
+0.024 (2.58%)
At close: Jun 26, 2026, 4:00 PM EDT
0.969
-0.002 (-0.21%)
After-hours: Jun 26, 2026, 7:18 PM EDT
Biofrontera Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Biofrontera stock have an average target of 6.00, with a low estimate of 3.00 and a high estimate of 9.00. The average target predicts an increase of 517.92% from the current stock price of 0.97.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 19, 2026.
Analyst Ratings
The average analyst rating for Biofrontera stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark Co. | Benchmark Co. | Buy Maintains $3 | Buy | Maintains | $3 | +208.96% | May 19, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $9 | Buy | Maintains | $9 | +826.88% | May 15, 2026 |
Financial Forecast
Revenue This Year
45.65M
from 41.71M
Increased by 9.45%
Revenue Next Year
52.68M
from 45.65M
Increased by 15.41%
EPS This Year
-0.16
from -1.19
EPS Next Year
0.32
from -0.16
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 45.9M | 53.2M | |
| Avg | 45.6M | 52.7M | |
| Low | 45.4M | 52.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.0% | 16.5% | |
| Avg | 9.4% | 15.4% | |
| Low | 8.9% | 14.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.16 | 0.32 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.